Live Terminal

Celanese Corporation (CE) is Selling Another 19% of Nutrinova for $152 Million. Is Deleveraging Worth Reducing Its Stake to 11%?

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Celanese Corporation (CE) is Selling Another 19% of Nutrinova for $152 Million. Is Deleveraging Worth Reducing Its Stake to 11%?
📊
Market & Financial Impact: Live financial intelligence and market filing report on ZeroLive.
💡
Actionable Insight: Monitor price volume action at market open; check key technical support/resistance levels.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Celanese Corporation (NYSE:CE) agreed to sell another 19% of the Nutrinova food-ingredients joint venture to Mitsui & Co., Ltd. for approximately $152 million in cash. The transaction, expected to close in the fourth quarter subject to customary conditions, will reduce the retained interest of Celanese Corporation (NYSE:CE) from 30% to 11%.

The interest being sold generated approximately $4 million of equity earnings in 2025. The consideration therefore equals about 38 times that contribution, suggesting Celanese Corporation (NYSE:CE) is receiving a strong price for a noncore holding. The proceeds will reduce debt, fund upcoming maturities, and count toward the goal of Celanese Corporation (NYSE:CE) to generate $1 billion from divestitures by the end of 2027.

The disclosed economics favor the sale. Paying $152 million for an interest that generated $4 million of equity earnings implies an earnings yield of only about 2.6% for the buyer. Celanese Corporation (NYSE:CE) is exchanging a relatively small earnings contribution for immediate debt-repayment capacity and potential interest savings.

Celanese Corporation (NYSE:CE) also retains 11% of Nutrinova, preserving some participation if the food-ingredients venture expands. Under the related diketene-facility arrangement, Nutrinova will cover the facility's full purchase price and ongoing operating costs. Celanese Corporation (NYSE:CE) has no funding obligation, limiting capital exposure while retaining an economic interest.

📰
Official Publisher Attribution: This report is aggregated from Yahoo Finance. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on Yahoo Finance ↗
Link copied to clipboard! ✅